Raymond James Financial’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Raymond James Financial's LLY Position: Q3 2026 in Review
Raymond James Financial increased its Eli Lilly (LLY) stake by 7.3% in Q3 2026, buying an estimated $148M and bringing the position to 1,839,206 shares worth $2.13B. The position accounts for 0.57% of the portfolio, ranked #23.
Raymond James Financial first reported a position in LLY in Q4 2024 and has held it in 8 quarters since. 4,106 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Raymond James Financial held 1,839,206 shares of Eli Lilly worth $2.13B as of Q3 2026.
- Raymond James Financial bought 125,356 Eli Lilly shares in Q3 2026, an estimated $148M.
- Eli Lilly made up 0.57% of Raymond James Financial's portfolio in Q3 2026, its #23 holding.
- Raymond James Financial first reported a position in Eli Lilly in Q4 2024 and has held it in 8 quarters since.
- 4,106 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Raymond James Financial's 13F filing for Q3 2026, filed 12 Nov 2026.